PURPOSE: The aim of this study was to address the efficacy of 2-[F-18]-Fluoro-2-deoxy-d-
glucose positron emission tomography (FDG-PET) in the staging of non-small cell lung …

Positron emission tomography (PET) using fluorine-18 deoxyglucose (FDG), showing
increased FDG uptake and retention in malignant cells, has been proven useful to …

Background and objective: Accurate staging at the time of diagnosis is very important in
deciding on the appropriate treatment for cancer patients. FDG PET indicates metabolic …

Introduction: Positron emission tomography (PET) using 18F-2-fluoro-2 deoxy-D-glucose
(FDG) has been widely investigated and used in the non-invasive imaging of malignancy …

Recent advances in positron emission tomography (PET) with 2-deoxy-2-fluoro [F-18]-d-
glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the …

The aim of this study was to determine whether quantitative information obtained from [18 F]
fluorodeoxyglucose positron emission tomography (18 F-FDG PET) has a prognostic …

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer morbidity and
mortality. Adjuvant chemotherapy improves survival in resected early-stage NSCLC …

Purpose/Objective: The utilities of positron emission tomography using 18F 2-fluoro-2-deoxy-
D-glucose (FDG-PET) for non-small cell lung cancer (NSCLC) are supposed to be (1) initial …

Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-d-glucose
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …

Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Tumour stage is the strongest prognostic factor and the most …